Adient PLC (ADNT - Free Report) reported adjusted earnings per diluted share of $1.15 in fourth-quarter fiscal 2020, beating the Zacks Consensus Estimate of 96 cents. This outperformance can be attributed to the higher-than-anticipated revenues from the company’s Americas segment. Better-than-expected contribution from each segment also drove the results.
Moreover, the bottom line compares favorably with the year-ago earnings of 63 cents per share, marking a year-over-year surge of 82.5%.
During the reported quarter, Adient generated net sales of $3,597 million, down from the $3,921 million recorded in the prior-year quarter, due to disappointing global production volumes. The top-line figure also missed the Zacks Consensus Estimate of $3,644 million.
Segmental Performance
Adient currently operates through three reportable segments — Americas, which includes North America and South America; Europe, Middle East, and Africa (EMEA); and Asia Pacific/China (Asia).
For the reported quarter, the Americas segment recorded revenues of $1,796 million, down from the $1,925 million generated in the year-ago period. The revenue figure, however, surpassed the Zacks Consensus Estimate of $1,782 million. Adient posted adjusted EBITDA of $111 million in the fiscal fourth quarter, up from the $64 million recorded in the prior-year period, primarily on lower selling, general and administration (SG&A) costs as well as positive business performance, partially offset by the negative impact of lower volumes. The metric also topped the consensus mark of $79 million.
For the fiscal fourth quarter, the EMEA segment registered revenues of $1,398 million, dropping 7.1% year over year. However, the reported figure marginally surpassed the consensus mark of $1,396 million. Its quarterly EBITDA came in at $84 million, higher than the prior-year quarter’s profit of $47 million. This upside resulted from decreased SG&A costs and a positive business performance, partially negated by the adverse impact of dismal volumes. The metric also topped the consensus mark of $51 million.
For the September-end quarter, revenues in the Asia segment came in at $460 million compared with the year-earlier quarter’s $558 million. The figure, moreover, missed the Zacks Consensus Estimate of $497 million. The company’s adjusted EBITDA was $113 million compared with the $126 million reported in fourth-quarter fiscal 2019 on lackluster industry volumes, slightly muted by rise in seating equity income and reduced SG&A costs. However, the metric topped the consensus mark of $105 million.
Financial Position
Adient had cash and cash equivalents of $1,692 million as of Sep 30, 2020, compared with $924 million as of Sep 30, 2019. As of the same date, long-term debt amounted to $4,097 million, up from $3,708 billion as of Sep 30, 2019. Capital expenditure declined to $68 million in the fiscal fourth quarter from the $118 million recorded in the prior-year quarter.
Fiscal 2020 Highlights
For the fiscal year, the company registered adjusted loss per diluted share of 4 cents compared with the earnings of $1.63 reported in the previous fiscal year.
Net sales for fiscal 2020 came in at $12,670 million, down from the $16,526 million reported in the prior fiscal year.
Fiscal 2021 Outlook
For fiscal 2021, Adient expects revenues of $14.6-$15 billion. Adjusted EBITDA is anticipated in the band of $1-$1.1 billion. Moreover, the company projects free cash flow of upto 100 million.
Zacks Rank & Other Stocks to Consider
Adient currently carries a Zacks Rank #2 (Buy). Shares of the company have appreciated 55.8%, year to date, while the industry has witnessed a rise of 12.3%.
Other top-ranked stocks in the auto sector include Autoliv, Inc. (ALV - Free Report) , Lear Corporation (LEA - Free Report) , Magna International (MGA - Free Report) , each sporting a Zacks Rank of 1 (Strong Buy), at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Adient PLC (ADNT - Free Report) reported adjusted earnings per diluted share of $1.15 in fourth-quarter fiscal 2020, beating the Zacks Consensus Estimate of 96 cents. This outperformance can be attributed to the higher-than-anticipated revenues from the company’s Americas segment. Better-than-expected contribution from each segment also drove the results.
Moreover, the bottom line compares favorably with the year-ago earnings of 63 cents per share, marking a year-over-year surge of 82.5%.
During the reported quarter, Adient generated net sales of $3,597 million, down from the $3,921 million recorded in the prior-year quarter, due to disappointing global production volumes. The top-line figure also missed the Zacks Consensus Estimate of $3,644 million.
Segmental Performance
Adient currently operates through three reportable segments — Americas, which includes North America and South America; Europe, Middle East, and Africa (EMEA); and Asia Pacific/China (Asia).
For the reported quarter, the Americas segment recorded revenues of $1,796 million, down from the $1,925 million generated in the year-ago period. The revenue figure, however, surpassed the Zacks Consensus Estimate of $1,782 million. Adient posted adjusted EBITDA of $111 million in the fiscal fourth quarter, up from the $64 million recorded in the prior-year period, primarily on lower selling, general and administration (SG&A) costs as well as positive business performance, partially offset by the negative impact of lower volumes. The metric also topped the consensus mark of $79 million.
For the fiscal fourth quarter, the EMEA segment registered revenues of $1,398 million, dropping 7.1% year over year. However, the reported figure marginally surpassed the consensus mark of $1,396 million. Its quarterly EBITDA came in at $84 million, higher than the prior-year quarter’s profit of $47 million. This upside resulted from decreased SG&A costs and a positive business performance, partially negated by the adverse impact of dismal volumes. The metric also topped the consensus mark of $51 million.
For the September-end quarter, revenues in the Asia segment came in at $460 million compared with the year-earlier quarter’s $558 million. The figure, moreover, missed the Zacks Consensus Estimate of $497 million. The company’s adjusted EBITDA was $113 million compared with the $126 million reported in fourth-quarter fiscal 2019 on lackluster industry volumes, slightly muted by rise in seating equity income and reduced SG&A costs. However, the metric topped the consensus mark of $105 million.
Financial Position
Adient had cash and cash equivalents of $1,692 million as of Sep 30, 2020, compared with $924 million as of Sep 30, 2019. As of the same date, long-term debt amounted to $4,097 million, up from $3,708 billion as of Sep 30, 2019. Capital expenditure declined to $68 million in the fiscal fourth quarter from the $118 million recorded in the prior-year quarter.
Fiscal 2020 Highlights
For the fiscal year, the company registered adjusted loss per diluted share of 4 cents compared with the earnings of $1.63 reported in the previous fiscal year.
Net sales for fiscal 2020 came in at $12,670 million, down from the $16,526 million reported in the prior fiscal year.
Fiscal 2021 Outlook
For fiscal 2021, Adient expects revenues of $14.6-$15 billion. Adjusted EBITDA is anticipated in the band of $1-$1.1 billion. Moreover, the company projects free cash flow of upto 100 million.
Zacks Rank & Other Stocks to Consider
Adient currently carries a Zacks Rank #2 (Buy). Shares of the company have appreciated 55.8%, year to date, while the industry has witnessed a rise of 12.3%.
Other top-ranked stocks in the auto sector include Autoliv, Inc. (ALV - Free Report) , Lear Corporation (LEA - Free Report) , Magna International (MGA - Free Report) , each sporting a Zacks Rank of 1 (Strong Buy), at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ALV - FREE
Get the latest research report on MGA - FREE
Get the latest research report on LEA - FREE
Get the latest research report on ADNT - FREE